Skip to content

The Impact of Sexual Health and Amputation Focused Education on Regulation of Glucose and Amputation Prevention

The Impact of Sexual Health and Amputation Focused Education on Regulation of Glucose and Amputation Prevention (SAFER GAP)

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04078854
Enrollment
21
Registered
2019-09-06
Start date
2020-07-08
Completion date
2022-03-16
Last updated
2023-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amputation; Traumatic, Limb, Diabetic Foot Ulcer Ischemic, Diabetic Ulcers on Both Feet, Sexual Dysfunction

Keywords

Diabetic Foot, Sexual Dysfunction, Amputation

Brief summary

The purpose of this study is to investigate the effect of two types of education on HbA1c level and future amputations in inpatient diabetics after initial minor foot amputation

Detailed description

This is a single center prospective randomized study evaluating inpatient diabetics after initial minor foot amputations. b) When a potential enrollee has been identified, while still inpatient, one research associate from a group of trained residents and medical students will spend 15-30 minutes with the patient to enroll and give one of the two education video presentations. The video presentations are the narrated versions of the slides attached to the IRB application. We will have both English and Spanish videos available. Because we are using video education, the education provided will be standardized across all patients, and there will be minimal variation in education provided despite using different research associates. The patients will be randomized to one of the two presentations. Both presentations are identical in educating patients how to control diabetes and the risk of future amputations in diabetes, but the experimental arm presentation will also include information regarding sexual dysfunction in diabetes. Each enrollee will also be asked if they are receiving structured diabetes education at the Montefiore Diabetic Center and will be encouraged to follow up to receive structured education there. The education presentation will occur after post-operative day 1 after minor foot amputations. Primary Outcome: HbA1c level Secondary Outcomes: LDL level, Mortality, Re-amputation (higher level or contralateral leg)

Interventions

BEHAVIORALDiabetes education

Both presentations are identical in educating patients how to control diabetes and the risk of future amputations in diabetes, but the experimental arm presentation will also include information regarding sexual dysfunction in diabetes.

Sponsors

Montefiore Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Masking description

Participants do not know that there are two types of presentations. When a potential enrollee has been identified, while still inpatient, one research associate from a group of trained residents or medical students will spend 15 to 30 minutes with the patient to enroll and give one of the two education video presentations. The patients will be randomized to one of the two presentations.

Intervention model description

The patients will be randomized to one of the two presentations. Both presentations are identical in educating patients how to control diabetes and the risk of future amputations in diabetes, but the experimental arm presentation will also include information regarding sexual dysfunction in diabetes.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* HbA1c 6.5 and above * had minor foot amputation this hospitalization * Age 18 years old and older * All ethnicities * Both genders

Exclusion criteria

None

Design outcomes

Primary

MeasureTime frameDescription
Change in hemoglobin A1c (HbA1c) levels3 months, 6 months, 1 year, 2 yearsHbA1c measures the amount of blood sugar (glucose) attached to hemoglobin

Secondary

MeasureTime frameDescription
Change in LDL Cholesterol levels3 months, 6 months, 1 year, 2 yearsLDL
Number of Deaths3 months, 6 months, 1 year, 2 yearsMortality
Number of amputations of lower extremities3 months, 6 months, 1 year, 2 yearsAmputation
Number of re-amputations3 months, 6 months, 1 year, 2 yearshigher level or contralateral leg
Number of patients with mobility problems3 months, 6 months, 1 year, 2 yearsNumber of blocks patient can walk before claudication

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026